Videos
PAVmed Inc. Completes Initial Public Offering
PAVmed Inc. Completes Initial Public Offering
Units began trading on Nasdaq under the ticker Symbol 'PAVMU.'
By Business Wire04.29.16
PAVmed Inc. announced today that it has completed its initial public offering of 1,060,000 units. Each unit consists of one share of common stock and one warrant. The units were sold at an offering price of $5.00 per unit, generating gross proceeds of $5.3 million.
Learn more about PAVmed's history by watching the video below:
The units begin trading on the Nasdaq Capital Market on April 28 under the ticker symbol “PAVMU.” Once the securities comprising the units begin separate trading, the common stock and warrants will trade on Nasdaq under the symbols “PAVM” and “PAVMW,” respectively.
The Benchmark Company, LLC acted as selling agent of the initial public offering.
PAVmed Inc. is a multi-product medical device company organized to conceive, develop and commercialize a diversified pipeline of products that address unmet clinical needs. PAVmed is further expanding its pipeline through engagements with clinician innovators and leading academic medical centers.
Learn more about PAVmed's history by watching the video below:
The units begin trading on the Nasdaq Capital Market on April 28 under the ticker symbol “PAVMU.” Once the securities comprising the units begin separate trading, the common stock and warrants will trade on Nasdaq under the symbols “PAVM” and “PAVMW,” respectively.
The Benchmark Company, LLC acted as selling agent of the initial public offering.
PAVmed Inc. is a multi-product medical device company organized to conceive, develop and commercialize a diversified pipeline of products that address unmet clinical needs. PAVmed is further expanding its pipeline through engagements with clinician innovators and leading academic medical centers.
Related Searches:
